Cargando…

In Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy Systemic Inflammation Response Index is a Useful Prognostic Indicator

Background: The preoperative systemic inflammation response index (SIRI), based on peripheral neutrophil (N), monocyte (M), and lymphocyte (L) counts, has shown mounting evidence as an effective prognostic indicator in some malignant tumors. The aim of the present study was to evaluate the prognosti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Li, Chen, Yong, Zhang, Lele, Xue, Yingwei, Zhang, Shiwei, Li, Xingrui, Song, Hongjiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pathology and Oncology Archive
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546636/ https://www.ncbi.nlm.nih.gov/pubmed/34712105 http://dx.doi.org/10.3389/pore.2021.1609811

Ejemplares similares

Pretreatment Systemic Immune-Inflammation Index Can Predict Response to Neoadjuvant Chemotherapy in Cervical Cancer at Stages IB2-IIB
por: Liu, Pingping, et al.
Publicado: (2022)

Thrombospondin 2 is a Functional Predictive and Prognostic Biomarker for Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy
por: Lin, Yuxiang, et al.
Publicado: (2022)

Predictive role of neostromal CD10 expression in breast cancer patients treated with neoadjuvant chemotherapy
por: Olah, Orsolya, et al.
Publicado: (2023)

Quantification of Ki67 Change as a Valid Prognostic Indicator of Luminal B Type Breast Cancer After Neoadjuvant Therapy
por: Tan, Shirong, et al.
Publicado: (2021)

Prognostic role of pretreatment skeletal muscle index in gastric cancer patients: A meta-analysis
por: He, Xiaohong, et al.
Publicado: (2023)

Systemic immune–inflammation index as a useful prognostic indicator predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy
por: Chen, Li, et al.
Publicado: (2017)

Prognostic value of systemic inflammation response index in hepatoblastoma patients receiving preoperative neoadjuvant chemotherapy
por: Zheng, Chen, et al.
Publicado: (2023)

Expression of SASP, DNA Damage Response, and Cell Proliferation Factors in Early Gastric Neoplastic Lesions: Correlations and Clinical Significance
por: Liang, Li, et al.
Publicado: (2022)

CircRNA: A new class of targets for gastric cancer drug resistance therapy
por: Zheng, Ying, et al.
Publicado: (2023)

The Pathologic Complete Response Ratio of Liver Metastases Represents a Valuable Prognostic Indicator
por: Xu, Yanbo, et al.
Publicado: (2022)

High expression of TMEM200A is associated with a poor prognosis and immune infiltration in gastric cancer
por: Deng, Hongyang, et al.
Publicado: (2023)

High Neutrophil-To-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammation Index (SII) Are Markers of Longer Survival After Metastasectomy of Patients With Liver-Only Metastasis of Rectal Cancer
por: Polk, Nándor, et al.
Publicado: (2022)

Corrigendum: High Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammation Index (SII) are Markers of Longer Survival After Metastasectomy of Patients With Liver-Only Metastasis of Rectal Cancer
por: Polk, Nándor, et al.
Publicado: (2022)

Emerging roles of the HECT E3 ubiquitin ligases in gastric cancer
por: Sun, Aiqin, et al.
Publicado: (2023)

Circular RNAs as Diagnostic and Prognostic Indicators of Colorectal Cancer: A Pooled Analysis of Individual Studies
por: Long, Cong, et al.
Publicado: (2022)

NAD+ biosynthesis metabolism predicts prognosis and indicates immune microenvironment for breast cancer
por: Yang, Yuting, et al.
Publicado: (2023)

Case report: Gastric adenosquamous carcinoma with EBV-positive component of squamous cell carcinoma mixed with gastric carcinoma with lymphoid stroma: A novel case report and literature review
por: Lu, Chang, et al.
Publicado: (2023)

Establishment of a Novel Prognostic Prediction Model for Gastric Cancer Based on Necroptosis-Related Genes
por: Zhu, Zhong-zhong, et al.
Publicado: (2022)

Inflammation in Focus: The Beginning and the End
por: L. Kiss, Anna
Publicado: (2022)

Clinical benefits of oral capecitabine over intravenous 5-fluorouracyl regimen in case of neoadjuvant chemoradiotherapy followed by surgery for locally advanced rectal cancer
por: Paszt, Attila, et al.
Publicado: (2022)

Ubiquitination-Related Molecular Subtypes and a Novel Prognostic Index for Bladder Cancer Patients
por: Cai, Hai, et al.
Publicado: (2021)

Clinicopathologic features of gastric glomus tumor: A report of 15 cases and literature review
por: Deng, Minying, et al.
Publicado: (2023)

Identification of a Gene Prognostic Model of Gastric Cancer Based on Analysis of Tumor Mutation Burden
por: Ma, Weijun, et al.
Publicado: (2021)

A Novel Glycolysis-Related Long Noncoding RNA Signature for Predicting Overall Survival in Gastric Cancer
por: Zeng, Jianmin, et al.
Publicado: (2022)

Influence of the microbiota on the effectiveness and toxicity of oncological therapies, with a focus on chemotherapy
por: Cazzaniga, Massimiliano, et al.
Publicado: (2023)

The Prognostic Role of PORT and EGFR Mutation Status in Completely Resected Stage IIIA/N2 Non-Small Cell Lung Cancer Patients with Postoperative Chemotherapy
por: Yang, Hui, et al.
Publicado: (2021)

Cytokine-induced killer cell treatment is superior to chemotherapy alone in esophageal cancer
por: Sun, Jiayang, et al.
Publicado: (2023)

A combined approach for individualized lymphadenectomy in gastric cancer patients
por: Varga, Zsolt, et al.
Publicado: (2023)

Association between radiomics features of DCE-MRI and CD8(+) and CD4(+) TILs in advanced gastric cancer
por: Huang, Huizhen, et al.
Publicado: (2023)

MET gene alterations predict poor survival following chemotherapy in patients with advanced cancer
por: Ko, Jihoon, et al.
Publicado: (2022)

Association Between DCE-MRI Perfusion Histogram Parameters and EGFR and VEGF Expressions in Different Lauren Classifications of Advanced Gastric Cancer
por: Li, Zhiheng, et al.
Publicado: (2022)

The Prognostic Value of Gastric Immune Prognostic Index in Gastric Cancer Patients Treated With PD-1/PD-L1 Inhibitors
por: Chen, Li, et al.
Publicado: (2022)

Identification of an Oxidative Stress-Related LncRNA Signature for Predicting Prognosis and Chemotherapy in Patients With Hepatocellular Carcinoma
por: Zhong, Zixuan, et al.
Publicado: (2022)

Expression and Potential Prognostic Value of SOX9, MCL-1 and SPOCK1 in Gastric Adenocarcinoma
por: Luo, Wenyi, et al.
Publicado: (2022)

Plasma Exosomal hsa_circ_0015286 as a Potential Diagnostic and Prognostic Biomarker for Gastric Cancer
por: Zheng, Peiming, et al.
Publicado: (2022)

Integrated oxidative stress score for predicting prognosis in stage III gastric cancer undergoing surgery
por: Liu, Yu-hang, et al.
Publicado: (2023)

Implication of ARID1A Undercurrents and PDL1, TP53 Overexpression in Advanced Gastric Cancer
por: Qadir, Jasiya, et al.
Publicado: (2021)

Genomic Landscape of Metastatic Lymph Nodes and Primary Tumors in Non-Small-Cell Lung Cancer
por: Chen, Bing, et al.
Publicado: (2022)

Prognostic Value of Highly Expressed Type VII Collagen (COL7A1) in Patients With Gastric Cancer
por: Oh, Sung Eun, et al.
Publicado: (2021)

Identifying Diagnostic and Prognostic Biomarkers and Candidate Therapeutic Drugs of Gastric Cancer Based on Transcriptomics and Single-Cell Sequencing
por: Zhao, Xu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mmlhqaqegdv725cvbdnc8buqcl